Technical Analysis for LIFE - aTyr Pharma, Inc.

Grade Last Price % Change Price Change
grade F 0.4476 -3.62% -0.02
LIFE closed down 3.62 percent on Monday, May 20, 2019, on 28 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical LIFE trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -3.62%
NR7 Range Contraction -3.62%
Lower Bollinger Band Walk Weakness -3.62%
Wide Bands Range Expansion -3.62%
Oversold Stochastic Weakness -3.62%
Boomer Sell Setup Bearish Swing Setup -2.70%
Narrow Range Bar Range Contraction -2.70%

Older signals for LIFE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
Organ Systems Muscular Dystrophy Dystrophy Myopathy Severe And Rare Diseases
Is LIFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.37
52 Week Low 0.375
Average Volume 524,146
200-Day Moving Average 0.5897
50-Day Moving Average 0.5395
20-Day Moving Average 0.5674
10-Day Moving Average 0.5132
Average True Range 0.0459
ADX 31.39
+DI 11.9894
-DI 27.8134
Chandelier Exit (Long, 3 ATRs ) 0.5822
Chandelier Exit (Short, 3 ATRs ) 0.5777
Upper Bollinger Band 0.7046
Lower Bollinger Band 0.4302
Percent B (%b) 0.06
BandWidth 48.360945
MACD Line -0.025
MACD Signal Line -0.0057
MACD Histogram -0.0193
Fundamentals Value
Market Cap 10.67 Million
Num Shares 23.8 Million
EPS -2.19
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.50
Resistance 3 (R3) 0.50 0.49 0.49
Resistance 2 (R2) 0.49 0.48 0.49 0.49
Resistance 1 (R1) 0.47 0.47 0.46 0.47 0.49
Pivot Point 0.45 0.45 0.45 0.45 0.45
Support 1 (S1) 0.43 0.44 0.43 0.43 0.41
Support 2 (S2) 0.42 0.43 0.42 0.41
Support 3 (S3) 0.40 0.42 0.40
Support 4 (S4) 0.40